Quarterly report pursuant to Section 13 or 15(d)

Condensed Consolidated Statements of Changes in Stockholders??? (Deficit) Equity (Unaudited)

v3.24.2.u1
Condensed Consolidated Statements of Changes in Stockholders’ (Deficit) Equity (Unaudited) - USD ($)
Common Stock
Additional Paid-in Capital
Accumulated Other Comprehensive Income
Accumulated Deficit
Total
Balance beginning at Dec. 31, 2022 $ 20 $ 121,637,966 $ (2,885,523) $ (107,408,545) $ 11,343,918
Balance beginning (in Shares) at Dec. 31, 2022 197,209        
Stock based compensation 557,421 557,421
Comprehensive income (loss):          
Net income (4,762,078) (4,762,078)
Other comprehensive income 663 663
Balance ending at Mar. 31, 2023 $ 20 122,195,387 (2,884,860) (112,170,623) 7,139,924
Balance ending (in Shares) at Mar. 31, 2023 197,209        
Balance beginning at Dec. 31, 2022 $ 20 121,637,966 (2,885,523) (107,408,545) 11,343,918
Balance beginning (in Shares) at Dec. 31, 2022 197,209        
Comprehensive income (loss):          
Net income         (8,442,247)
Other comprehensive income         (14,604)
Balance ending at Jun. 30, 2023 $ 28 125,466,694 (2,900,127) (115,850,792) 6,715,803
Balance ending (in Shares) at Jun. 30, 2023 279,877        
Balance beginning at Mar. 31, 2023 $ 20 122,195,387 (2,884,860) (112,170,623) 7,139,924
Balance beginning (in Shares) at Mar. 31, 2023 197,209        
Issuance of April 2023 pre-funded and common warrants, net 2,337,706     2,337,706
Shares issued from exercise of April 2023 pre-funded warrants $ 6 111     117
Shares issued from exercise of April 2023 pre-funded warrants (in Shares) 61,615        
Shares issued in connection with April 2023 Offering, net $ 2 382,180     382,182
Shares issued in connection with April 2023 Offering, net (in Shares) 21,053        
Stock based compensation 551,310 551,310
Comprehensive income (loss):          
Net income (3,680,169) (3,680,169)
Other comprehensive income (15,267) (15,267)
Balance ending at Jun. 30, 2023 $ 28 125,466,694 (2,900,127) (115,850,792) 6,715,803
Balance ending (in Shares) at Jun. 30, 2023 279,877        
Balance beginning at Dec. 31, 2023 $ 54 130,117,209 (2,901,339) (127,343,657) (127,733)
Balance beginning (in Shares) at Dec. 31, 2023 534,719        
Shares issued from exercise of pre-funded warrants related to Amendment to August 2023 Offering $ 26 463 489
Shares issued from exercise of pre-funded warrants related to Amendment to August 2023 Offering (in Shares) 257,205        
Adjustment related to reverse stock split in February 2024 $ 6 (6)
Adjustment related to reverse stock split in February 2024 (in Shares) 60,848        
Stock based compensation 236,062 236,062
Comprehensive income (loss):          
Net income (1,069,744) (1,069,744)
Other comprehensive income 6,460 6,460
Balance ending at Mar. 31, 2024 $ 86 130,353,728 (2,894,879) (128,413,401) (954,466)
Balance ending (in Shares) at Mar. 31, 2024 852,772        
Balance beginning at Dec. 31, 2023 $ 54 130,117,209 (2,901,339) (127,343,657) (127,733)
Balance beginning (in Shares) at Dec. 31, 2023 534,719        
Comprehensive income (loss):          
Net income         (1,057,963)
Other comprehensive income         (14,401)
Balance ending at Jun. 30, 2024 $ 95 130,899,278 (2,915,740) (128,401,620) (417,987)
Balance ending (in Shares) at Jun. 30, 2024 941,590        
Balance beginning at Mar. 31, 2024 $ 86 130,353,728 (2,894,879) (128,413,401) (954,466)
Balance beginning (in Shares) at Mar. 31, 2024 852,772        
Shares issued for settlement of liabilities $ 9 523,242 523,251
Shares issued for settlement of liabilities (in Shares) 88,818        
Stock based compensation 22,308 22,308
Comprehensive income (loss):          
Net income 11,781 11,781
Other comprehensive income (20,861) (20,861)
Balance ending at Jun. 30, 2024 $ 95 $ 130,899,278 $ (2,915,740) $ (128,401,620) $ (417,987)
Balance ending (in Shares) at Jun. 30, 2024 941,590